BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/29/2026 7:26:45 AM | Browse: 1 | Download: 16
 |
Received |
|
2025-12-30 06:46 |
|
Peer-Review Started |
|
2025-12-30 06:51 |
|
First Decision by Editorial Office Director |
|
2026-01-08 09:55 |
|
Return for Revision |
|
2026-01-08 09:55 |
|
Revised |
|
2026-01-30 15:55 |
|
Publication Fee Transferred |
|
2026-02-09 06:54 |
|
Second Decision by Editor |
|
2026-03-18 02:37 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-03-18 05:50 |
|
Articles in Press |
|
2026-03-18 05:50 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-05-18 00:50 |
|
Publish the Manuscript Online |
|
2026-05-29 07:26 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Observational Study |
| Article Title |
Serial circulating tumor DNA as a biomarker for monitoring and prognostication in patients with pancreatic cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Kwangrok Jung, Jongchan Lee, Dayeon Jang, Jinwoo Ahn, Bomi Kim, Soomin Yang, Jae Hyeong Kim, Yuna Youn, Jong-Chan Lee, Jaihwan Kim and Jin-Hyeok Hwang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Research Foundation of Korea |
RS-2021-NR059201 |
| Seoul National University Bundang Hospital Research Fund |
06-2019-0069 |
|
| Corresponding Author |
Jin-Hyeok Hwang, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, 82, Gumi-ro 173 Beon-gil, Bundang-gu, Seongnam-si 13620, Gyeonggi-do, South Korea. woltoong@snu.ac.kr |
| Key Words |
Circulating tumor DNA; Pancreatic ductal adenocarcinoma; Liquid biopsy; Serial monitoring; Treatment response; Prognosis |
| Core Tip |
This study highlights the emerging role of circulating tumor DNA (ctDNA) as a clinically relevant biomarker in pancreatic ductal adenocarcinoma. ctDNA offers a minimally invasive approach for serial disease monitoring and may provide complementary information to conventional imaging and tumor markers for treatment assessment and prognostication. In the setting of limited effective biomarkers for this malignancy, ctDNA represents a promising tool for improving clinical management. |
| Publish Date |
2026-05-29 07:26 |
| Citation |
Jung K, Lee J, Jang D, Ahn J, Kim B, Yang S, Kim JH, Youn Y, Lee JC, Kim J, Hwang JH. Serial circulating tumor DNA as a biomarker for monitoring and prognostication in patients with pancreatic cancer. World J Gastroenterol 2026; 32(22): 118323 |
| URL |
https://www.wjgnet.com/1007-9327/full/v32/i22/118323.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v32.i22.118323 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
